Bilepton effects on the WWV^* vertex in the 331 model with right-handed neutrinos via a SU_L(2)XU_Y(1) covariant quantization scheme

In a recent paper, we investigated the effects of the massive charged gauge bosons (bileptons) predicted by the minimal 331 model on the off-shell vertex WWV^* (V=gamma, Z) using a SU_L(2) X U_Y(1) covariant gauge-fixing term for the bileptons. We proceed along the same lines and calculate the effects of the gauge bosons predicted by the 331 model with right-handed neutrinos. It is found that the bilepton effects on the WWV^* vertex are of the same order of magnitude than those arising from the SM and several of its extensions, provided that the bilepton mass is of the order of a few hundred of GeVs. For heavier bileptons, their effects on the WWV^* vertex are negligible. The behavior of the form factors at high energies is also discussed as it is a reflect of the gauge invariance and gauge independence of the WWV^* Green function obtained via our quantization method.Comment: Replaced to match published versio

Static quantities of a neutral bilepton in the 331 model with right-handed neutrinos

A neutral vector boson can possess static electromagnetic properties provided that the associated field is no self-conjugate. This possibility is explored in the $SU_C(3) X SU_L(3) X U_N(1)$ model with right-handed neutrinos, which predicts a complex neutral gauge boson $Y^0$ in a nontrivial representation of the electroweak group. In this model the only nonvanishing form factors are the CP-even ones, which arise from both the quark and gauge sectors, and contribute to the magnetic dipole and the electric quadrupole moments of this neutral particle.Comment: 10 pages, 6 figures, submitted to Phys. Rev.

Rare three-body decay t -> c h gamma in the standard model and the two-Higgs doublet model

A complete calculation of the rare three-body decay t --> c h gamma is presented in the framework of the standard model. In the unitary gauge, such a calculation involves about 20 Feynman diagrams. We also calculate this decay in the general two-Higgs doublet model (model III), in which it arises at the tree-level. While in the standard model the decay t --> c h gamma is extremely suppressed, with a branching fraction of the order of $10^{-15}$ for a Higgs boson mass of the order of 115 GeV, in the model III it may have a branching ratio up to $10^{-5}$. We also discuss the crossed decay h --> b \bar{s} gamma.Comment: Updated to match published versio

Fermion contribution to the static quantities of arbitrarily charged vector bosons

We present an analysis of the one-loop contribution from left- and right-handed fermions to the static electromagnetic properties of an arbitrarily charged no self-conjugate vector boson $V$. Particular emphasis is given to the case of a no self-conjugate neutral boson $V^0$. Regardless the electric charge of the $V$ boson, a fermionic loop can induce the two CP-even form factors but only one CP-odd. As a result the corresponding electric dipole moment is directly proportional to the magnetic quadrupole moment. The CP-odd form factor might be severely suppressed since it requires the presence of both left- and right-handed fermions. The behavior of the form factors is analyzed for several scenarios of the fermion masses in the context of the decoupling theorem.Comment: 12 pages, 3 figures, submitted to Journal of Physics

Static quantities of the W boson in the SU_L(3) X U_X(1) model with right-handed neutrinos

The static electromagnetic properties of the $W$ boson, $\Delta \kappa$ and $\Delta Q$, are calculated in the SU_L(3)} \times U_X(1) model with right-handed neutrinos. The new contributions from this model arise from the gauge and scalar sectors. In the gauge sector there is a new contribution from a complex neutral gauge boson $Y^0$ and a singly-charged gauge boson $Y^\pm$. The mass of these gauge bosons, called bileptons, is expected to be in the range of a few hundreds of GeV according to the current bounds from experimental data. If the bilepton masses are of the order of 200 GeV, the size of their contribution is similar to that obtained in other weakly coupled theories. However the contributions to both $\Delta Q$ and $\Delta \kappa$ are negligible for very heavy or degenerate bileptons. As for the scalar sector, an scenario is examined in which the contribution to the $W$ form factors is identical to that of a two-Higgs-doublet model. It is found that this sector would not give large corrections to $\Delta \kappa$ and $\Delta Q$.Comment: New material included. Final version to apppear in Physical Review

Two-body Z′Z' decays in the minimal 331 model

The two-body decays of the extra neutral boson Z_2 predicted by the minimal 331 model are analyzed. At the three-level it can decay into standard model particles as well as exotic quarks and the new gauge bosons predicted by the model. The decays into a lepton pair are strongly suppressed, with $Br(Z_2 --> l^+l^-) ~ 10^{-2}$ and $Br(Z_2 --> \bar{\nu}_l \nu) ~ 10^{-3}$. In the bosonic sector, Z_2 would decay mainly into a pair of bilepton gauge bosons, with a branching ratio below the 0.1 level. The Z_2 boson has thus a leptophobic and bileptophobic nature and it would decay dominantly into quark pairs. The anomaly-induced decays $Z_2 --> Z_1\gamma$ and $Z_2 --> Z_1Z_1$, which occurs at the one-loop level are studied. It is found that $Br(Z_2 --> Z_1\gamma) ~ 10^{-9}$ and $Br(Z_2 --> Z_1Z_1) ~ 10^{-6}$ at most. As for the $Z_2 --> W^+W^-$ and $Z_2 --> Z_1H$ decays, with H a relatively light Higgs boson, they are induced via Z'-Z mixing. It is obtained that $Br(Z_2 --> W^+W^-) ~ 10^{-2}$ and $Br (Z_2 --> Z_1H) ~ 10^{-5}$. We also examine the flavor changing neutral current decays $Z_2 --> tc$ and $Z_2 --> tu$, which may have branching fractions as large as $10^{-3}$ and $10^{-5}$, respectively, and thus may be of phenomenological interest.Comment: 14 pages, 3 figures, submitted to Physical Review

Epidemiology of Superficial Fungal Infections in Portugal: 3-year review (2014-2016)

Introdução: As infeções fúngicas superficiais são as dermatoses infeciosas mais frequentes e a sua incidência continua a aumentar. Os dermatófitos são os principais agentes causais apresentando, contudo, uma distribuição geográfica variável. Material e Métodos: O presente estudo teve como objetivo a caracterização epidemiológica das infeções fúngicas superficiais diagnosticadas nos Serviços/Unidades de Dermatologia pertencentes ao Serviço Nacional de Saúde Português entre janeiro de 2014 e dezembro 2016 através da análise retrospetiva dos resultados das culturas realizadas durante esse período. Resultados: Foram estudados 2375 isolamentos, pertencentes a 2319 doentes. O dermatófito mais frequentemente isolado foi o Trichophyton rubrum (53,6%), tendo sido o principal agente causal da tinha da pele glabra (52,4%) e das onicomicoses (51,1%). Relativamente às tinhas do couro cabeludo, globalmente o Microsporum audouinii foi o agente mais prevalente (42,6%), seguido do Trichophyton soudanense (22,1%). Enquanto na área metropolitana de Lisboa estes dermatófitos foram os principais agentes de tinha do couro cabeludo, nas regiões Norte e Centro o agente mais frequente foi o Microsporum canis (58,5%). Os fungos leveduriformes foram os principais responsáveis pelas onicomicoses das mãos (76,7%). Conclusão: Os resultados deste estudo estão globalmente concordantes com a literatura científica. O Trichophyton rubrum apresenta-se como o dermatófito mais frequentemente isolado em cultura. Na tinha do couro cabeludo, na área metropolitana de Lisboa, as espécies antropofílicas de importação assumem particular destaque.info:eu-repo/semantics/publishedVersio

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks